The new drug development -- collaborative and people-powered
Guest Commentary: EMD Serono and iConquerMS discuss their approach to patient-centricity
In recent years, the healthcare ecosystem has been experiencing a paradigm shift in how it engages with the people at its center: patients.
Patients are demanding to be viewed first as people, with lives and priorities that exist outside the door of the clinical examination room. They insist on having a voice in how the conditions that impact them are studied and treated.
This shift in engagement requires a corresponding shift in our clinical research infrastructure -- one that keeps patients’ needs and priorities at its core.
A new model must be created to meaningfully incorporate patient participation, and patient-contributed health information, through all aspects of clinical trials, with patients